» Subscribe Today!
The Power of Information
Home
The Ledger - EST. 1978 - Nashville Edition
X
Skip Navigation LinksHome > Name & Property Search

Name & Property Search

Search results for 'regeneron pharmaceuticals' | Search again
DeSoto Public Records:0
Shelby Public Records:0
Editorial:26
West Tennessee:0
Middle Tennessee:0
East Tennessee:0
Other:0

You must be a subscriber to see the full results of your search.

Please log in or subscribe below if you are not already a subscriber.

TNLedger Knoxville Edition subscribers get full access to more than 13 million names and addresses along with powerful search and download features. Get the business leads you need with powerful searches of public records and notices. Download listings into your spreadsheet or database.

Learn more about our services | Search again


Editorial Results (free)

1. Paycom Software's Richison, AMD's Su among highest paid CEOs -

Here are the highest paid male and female CEOs in the S&P 500 index for 2020, as calculated by The Associated Press and Equilar, an executive data firm.

The AP's compensation study covered 342 executives at S&P 500 companies who have served at least two full consecutive fiscal years at their respective companies, which filed proxy statements between Jan. 1 and April 30. Some companies with highly paid CEOs do not fit these criteria.

2. Indians turn to black market, unproven drugs as virus surges -

NEW DELHI (AP) — Ashish Poddar kept an ice pack on hand as he waited outside a New Delhi hospital for a black market dealer to deliver two drugs for his father, who was gasping for breath inside with COVID-19.

3. Studies extend hopes for antibody drugs against COVID-19 -

New results extend hopes for drugs that supply antibodies to fight COVID-19, suggesting they can help keep patients out of the hospital and possibly prevent illness in some uninfected people.

Eli Lilly said Tuesday that a two-antibody combo reduced the risk of hospitalizations or death by 70% in newly diagnosed, non-hospitalized COVID-19 patients at high risk of serious illness because of age or other health conditions. All 10 deaths that occurred in the study were among those receiving placebo rather than the antibodies.

4. Stocks rise on Wall Street on latest hopes for virus vaccine -

More encouraging news on the development of coronavirus vaccines and treatments helped power stocks higher on Wall Street Monday, as the market clawed back most of its losses from last week.

The S&P 500 index rose 0.6%, led by banks, energy and industrial companies, sectors that have been beaten down during the pandemic. Health care and technology stocks, which traders have bid up sharply this year, closed lower. Treasury yields mostly rose, another sign of optimism among investors.

5. US allows 1st emergency use of a COVID-19 antibody drug -

WASHINGTON (AP) — U.S. health officials have allowed emergency use of the first antibody drug to help the immune system fight COVID-19, an experimental approach against the virus that has killed more than 238,000 Americans.

6. 2nd study testing a COVID-19 antibody drug has a setback -

For the second time, a study testing an experimental antibody drug for COVID-19 has been paused to investigate a possible safety issue in hospitalized patients.

Regeneron Pharmaceuticals Inc. said Friday that independent monitors had recommended placing on hold enrollment of the most severely ill patients -- those who need intense oxygen treatment or breathing machines -- because of a potential safety problem and unfavorable balance of risks and benefits.

7. AP FACT CHECK: Trump's shaky claims on virus, Dem misfires -

WASHINGTON (AP) — Impatient to return to the campaign trail, President Donald Trump dubiously claimed he's fully recovered and immune from COVID-19, hailed a cure that isn't so and declared the coronavirus is "disappearing" even as cases spiked.

8. Antibody drugs are no cure but seem promising for COVID-19 -

WASHINGTON (AP) — They're not cures and it's not likely that everyone will be able to get them as President Donald Trump has suggested. But experimental antibody drugs like the one Trump was given are among the most promising therapies being tested for treating and preventing coronavirus infections.

9. Lilly seeks emergency use of its antibody drug for COVID-19 -

A drug company says it has asked the U.S. government to allow emergency use of an experimental antibody therapy based on early results from a study that suggested the drug reduced symptoms, the amount of virus, hospitalizations and ER visits for patients with mild or moderate COVID-19.

10. Trump says he's leaving hospital for White House, feels good -

BETHESDA, Md. (AP) — President Donald Trump said Monday he's leaving the military hospital where he has been treated for COVID-19 and will continue his recovery at the White House. He said he's feeling good and the nation should not be afraid of the virus that has killed more than 209,000 Americans.

11. What we know, and what we don't, about Trump's diagnosis -

WASHINGTON (AP) — Some answers emerged Saturday on President Donald Trump's condition as he battles the coronavirus, but Trump's medical team withheld some key information in their first full, televised update.

12. Can blood from coronavirus survivors treat the newly ill? -

WASHINGTON (AP) — Hospitals are gearing up to test if a century-old treatment used to fight off flu and measles outbreaks in the days before vaccines, and tried more recently against SARS and Ebola, just might work for COVID-19, too: using blood donated from patients who've recovered.

13. Behind the scenes, scientists prep for COVID-19 vaccine test -

WASHINGTON (AP) — A team of scientists jostled for a view of the lab dish, staring impatiently for the first clue that an experimental vaccine against the new coronavirus just might work.

After weeks of round-the-clock research at the National Institutes of Health, it was time for a key test. If the vaccine revs up the immune system, the samples in that dish -- blood drawn from immunized mice -- would change color.

14. US stocks cap milestone-setting week with modest losses -

Bond yields rose and stocks mostly bounced back from an early slide to finish with modest losses Friday, a downbeat end on Wall Street to an otherwise milestone-setting week for the broader market.

15. Top 10 highest-paid CEOs -

Here are the 10 highest-paid CEOs for 2016, as calculated by The Associated Press and Equilar, an executive data firm.

___

1. Thomas Rutledge

16. Higher wages push stocks to records, but Dow misses 20,000 -

NEW YORK (AP) — So close! The Dow Jones industrial average missed the 20,000 mark by a fraction of a point Friday as U.S. stock indexes rose after the government said wages jumped in December. Two other major indexes set records.

17. US stock market notches biggest gain in 8 months; oil rises -

The U.S. stock market rebounded from a nine-day losing streak Monday, posting its biggest gain in eight months and driving the Dow Jones industrial average up more than 370 points.

Financial stocks led the broad market rally, which erased more than half of the losses racked up by the Standard & Poor's 500 index since October 25.

18. US stocks can't hang onto gains, finish lower -

NEW YORK (AP) — U.S. stocks wobbled and finished mostly lower Monday as investors waited for central bank meetings in the United States and Japan. Health care and technology companies took some of the biggest losses while banks rose.

19. Stocks end mostly lower in quiet trade; oil prices decline -

NEW YORK (AP) — Stocks closed slightly lower in quiet trading Monday after drifting most of the day between gains and losses. Energy companies fell along with the price of oil while biotechnology and drug companies rose after Pfizer announced it was buying a cancer drug maker.

20. Top 10 highest-paid CEOs -

Here are the 10 highest-paid CEOs for 2015, as calculated by The Associated Press and Equilar, an executive data firm.

1. Dara Khosrowshahi, Expedia, $94.6 million, up 881 percent. Expedia's stock return last fiscal year: 47 percent.

21. US stocks recover from an early slump and close higher -

Energy companies led a broad rally in U.S. stocks Monday as investors shrugged off another slide in crude oil prices.

The gain nudged the Dow Jones industrial average slightly above the 18,000-point mark for the first time since last summer, while the Standard & Poor's 500 index rose to the highest level in a year.

22. US stocks jump after solid March jobs report -

NEW YORK (AP) — U.S. stocks climbed Friday after the government said job growth continued at a strong clip in March. Makers of consumer goods and household products rose, and health care companies rebounded. The solid employment report helped U.S. stocks stay out of a steep global decline.

23. An up-and-down day for stock market ends with a solid gain -

NEW YORK (AP) — Stocks posted solid gains in a quiet session Wednesday, helped by advances in health-care and industrial companies.

Without any major economic reports to work with, trading was lighter than usual. Many investors remain on the sidelines ahead of Thursday's release of minutes from the Federal Reserve's latest policy meeting and the start of corporate earnings season.

24. Top 10 highest-paid CEOs -

NEW YORK (AP) — Here are the 10 highest-paid CEOs for 2014, as calculated by The Associated Press and Equilar, an executive pay data firm:

1. David Zaslav, Discovery Communications, $156.1 million, up 368 percent

25. Top 10 highest-paid CEOs -

NEW YORK (AP) — Here are the 10 highest-paid CEOs of 2013, as calculated by The Associated Press and Equilar, an executive pay research firm:

1. Anthony Petrello, Nabors Industries, $68.2 million, up 246 percent

26. US stocks edge higher in afternoon trading -

Stocks held on to modest gains in afternoon trading Thursday, building on the prior day's rebound. Investors were encouraged by reports on Chinese manufacturing, U.S. home sales and some positive earnings from Best Buy, Dollar Tree and other retailers.